Active substancePegaptanibPegaptanib
Similar drugsTo uncover
  • Makugen
    solution for injections 
       
  • Dosage form: & nbspSolution for injection into the vitreous
    Composition:Active substance: pegaptanib sodium - 0.3 mg;
    Excipients: sodium dihydrogen phosphate monohydrate, sodium hydrogen phosphate heptahydrate, sodium chloride, hydrochloric acid, sodium hydroxide, water.

    ATX: & nbsp

    S.01.L.A.03   Pegaptanib

    Indications:
    • Age-related macular degeneration is a neovascular form (wet).
    Contraindications:
    • Hypersensitivity to the components of the drug.
    • Eye / periocular infection
    • Childhood.
    • Pregnancy.
    With caution, the drug is prescribed during breastfeeding.
    Pregnancy and lactation:Contraindicated.
    Dosing and Administration:Makugzhen injected into the vitreous body for one dose every 6 weeks, up to 9 injections per year.
    The injection into the vitreous body is authorized by an ophthalmologist who has sufficient experience in administering intravitreal injections strictly in sterile conditions with concomitant anesthesia.
    Overdose:no data.
    Interaction:no data.
    Form release / dosage:Solution for intravitreal administration.
    Packaging:Syringe for injection 90 mcg in a pack of cardboard with instructions.
    Terms of leave from pharmacies:On prescription
    Illustrated instructions
      Instructions
      Up